Epilepsy News

Recent news about epilepsy, seizures and treatments.

News Feeds

Epilepsy and Seizure News

Epilepsy awareness in the workplace: training and safety tips - More than 35,000 Long Islanders live with epilepsy. Experts urge businesses to provide seizure training, safety plans, and awareness to protect employees and customers.

Many people have seizures. Here's why that doesn’t always mean epilepsy. - One of the most common causes of epilepsy is a structural brain abnormality. “Epilepsy can result from structural issues in the brain, such as brain tumors, brain injuries, brain infections or ...

Health Beat: Treating epilepsy - Nearly three million Americans live with epilepsy. And for one-third of them, anti-seizure medications don't work.

Epileptic seizure alert wearable set to launch in Europe in 2026 - Episera, which is intended for homecare and ambulatory use, is the first digital health tool for real-time early seizure detection, according to the companies. The device is classified as a Class IIa ...

Epilepsy myths you must stop believing: Expert busts the biggest misconceptions - Epilepsy is still surrounded by harmful myths and stigma. This expert-backed guide breaks down the most common misconceptions, explains what seizures really are, how epilepsy is diagnosed, what ...

Orcutt Driver with Seizure Disorder Must Stand Trial for Fatal Crash, Judge Rules - A Santa Maria Valley man whose driver’s license had been suspended several times due to his seizure disorder must stand trial on a second-degree murder ...

‘A thunderstorm in the brain’: Advocate shares journey to raise awareness, break stigmas during National Epilepsy Awareness Month - As part of National Epilepsy Awareness Month this November, a local advocate from the Epilepsy Foundation of Virginia is using his story to make a difference.

Stoke Therapeutics and Biogen Announce Presentations at the 2025 American Epilepsy Society Annual Meeting - New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in patients with Dravet syndrome treated with zorevunersen support the ...

How Do Cavernous Malformations Affect Seizure Risk? - The risk for a first-ever epileptic seizure after cerebral cavernous malformations is low, with younger age and initial presentation with epileptic seizures being significant risk factors.

Medical News Today

PubMed

Clinical and Genetic Spectrum of SCN8A-Related Disorders: A Retrospective Study From the Gulf Region - This multicenter retrospective study examined the clinical characteristics and outcomes of 26 patients with sodium channel protein type 8 subunit alpha (SCN8A)-related epilepsy and/or neurodevelopmental disorders across the Gulf region. Data were collected from August 2024 to January 2025. Most patients (80.77%) experienced epilepsy onset within the first year of life, with a mean onset age of ...

Metformin as a Neuroendocrine Modulator in Catamenial Epilepsy: Interplay with Sex Hormones and Neurosteroids - Catamenial epilepsy (CE) is a hormone-sensitive neurological condition characterized by the cyclical exacerbation of seizures in relation to the menstrual cycle. This condition arises from fluctuations in sex hormones, particularly elevated estrogen and diminished progesterone levels, which disrupt the excitatory-inhibitory balance within the brain. Neurosteroids, such as allopregnanolone, whic...

The Role of HIF-1alpha/BNIP3 Pathway in Hippocampal Neuronal Autophagy in Epilepsy - Epilepsy (EP), a prevalent neurological disorder, lacks a comprehensive understanding of the molecular mechanisms underlying epileptogenesis. Multiple studies highlight that hippocampal (Hip) neuronal injury may serve as an essential underlying factor in EP onset and progression. Accumulating evidence shows that autophagy (Apg) has an essential function in supporting cell survival and sustainin...

Relieving the Weight: Fenfluramine's Re-emergence as Antiseizure Medication for Lennox-Gastaut and Dravet Syndrome - CONCLUSIONS: As seen through the results of multiple clinical trials, fenfluramine can provide significant seizure reduction for Lennox-Gastaut and Dravet patients with treatment-resistant seizures. Risks can be mitigated through adherence to proper programs and schedules, and can provide enough benefits to outweigh risks in patients with particularly resistant epilepsies.

Switch-Off response to mid-cingulate cortex stimulation: a video case report - CONCLUSION: This case represents a rare video-documentation of stimulation-induced complex motor and behavioural response localised to the mid-cingulate cortex and supports mid-cingulate's role as connection hub for volitional control and sensorimotor integration.

Seizures, climate and pollution: is there evidence of an association? - CONCLUSION: Cold temperatures and elevated NO(2) levels are independently associated with an increased number of seizure-related emergency admissions. These findings highlight the potential neurological impact of air pollution and extreme weather, emphasizing the need for preventive public health measures and further research to clarify the underlying mechanisms.

Science Daily

Brain signal irregularity may provide clues to understanding epileptic process - Researchers propose a new method to differentiate signals from the epileptic focus from those recorded in other parts of the brain without the presence of an epileptic seizure. This technique may help detect epilepsy-induced features from these signals much quicker than conventional analysis techniques.

Breakthrough tech enables seizure localization in minutes - New research introduces a novel network analysis technology that uses minimally invasive resting state electrophysiological recordings to localize seizure onset brain regions and predict seizure outcomes in just 10 minutes.

Antidepressant use during pregnancy not linked to epilepsy in children - A new study suggests that antidepressant use by mothers during the first trimester of pregnancy does not increase the chances of epilepsy and seizures in babies.

Back
Top Bottom